These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32866813)

  • 81. Follow-up of adults with noncritical COVID-19 two months after symptom onset.
    Carvalho-Schneider C; Laurent E; Lemaignen A; Beaufils E; Bourbao-Tournois C; Laribi S; Flament T; Ferreira-Maldent N; Bruyère F; Stefic K; Gaudy-Graffin C; Grammatico-Guillon L; Bernard L
    Clin Microbiol Infect; 2021 Feb; 27(2):258-263. PubMed ID: 33031948
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Assessment of smell disturbances 6 months after COVID-19 in Polish population.
    Okrzeja J; Sołomacha S; Alimowski M; Sowa P; Dubatówka M; Łapińska M; Kiszkiel Ł; Szczerbiński Ł; Laskowski PP; Czupryna P; Kubas B; Garkowski A; Kamiński KA; Moniuszko-Malinowska A
    Sci Rep; 2024 May; 14(1):11251. PubMed ID: 38755270
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Airborne aerosol olfactory deposition contributes to anosmia in COVID-19.
    Workman AD; Jafari A; Xiao R; Bleier BS
    PLoS One; 2021; 16(2):e0244127. PubMed ID: 33544701
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Low-cost technology for COVID-19 infection detection through smell loss test: An overview.
    Swain KC; Singha C
    Trop Biomed; 2020 Sep; 37(3):671-682. PubMed ID: 33612781
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Symptoms Reported With New Onset of Loss of Taste or Smell in Individuals With and Without SARS-CoV-2 Infection.
    Koyama AK; Siegel DA; Oyegun E; Hampton W; Maddox N; Koumans EH
    JAMA Otolaryngol Head Neck Surg; 2021 Oct; 147(10):911-914. PubMed ID: 34473217
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Revealing the mystery of persistent smell loss in Long COVID patients.
    Park JW; Wang X; Xu RH
    Int J Biol Sci; 2022; 18(12):4795-4808. PubMed ID: 35874953
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prevalence and Recovery from Newly Onset Anosmia and Ageusia in Covid 19 Patients at our Teritary Care Centre.
    Kandakure VT; Valvi HR; Khokle P; More MS; Chouhan R
    Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3399-3406. PubMed ID: 33868972
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prevalence and characteristics of persistent symptoms after non-severe COVID-19: a prospective cohort study.
    Armange L; Bénézit F; Picard L; Pronier C; Guillot S; Lentz PA; Carré F; Tattevin P; Revest M
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2421-2425. PubMed ID: 33893570
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Paediatric olfactory dysfunction: a chance to detect COVID-19?
    Hall A; Frauenfelder C; Butler C; Coyle P; Hopkins C
    Arch Dis Child; 2021 Mar; 106(3):e17. PubMed ID: 32819914
    [No Abstract]   [Full Text] [Related]  

  • 90. How does Covid-19 infection affect smell?
    Henkin RI
    Am J Otolaryngol; 2021; 42(3):102912. PubMed ID: 33540233
    [No Abstract]   [Full Text] [Related]  

  • 91. Loss of olfactory sensitivity is an early and reliable marker for COVID-19.
    Iravani B; Arshamian A; Lundström JN
    Chem Senses; 2022 Jan; 47():. PubMed ID: 36069508
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The incidence of anosmia in patients with laboratory-confirmed COVID 19 infection in India: An observational study.
    Kumar V; Singla S; Gupta N; Bharati SJ; Garg R; Pandit A; Vig S; Mishra S; Bhatnagar S
    J Anaesthesiol Clin Pharmacol; 2021; 37(1):51-56. PubMed ID: 34103823
    [TBL] [Abstract][Full Text] [Related]  

  • 93. On the relationship between neurocognitive measures and olfactory dysfunction in COVID-19 patients with and without anosmia.
    Mahali M; Coolidge FL
    Brain Behav Immun Health; 2023 Jul; 30():100632. PubMed ID: 37215309
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Focus on uncommon symptoms of COVID-19: Potential reason for spread of infection.
    Pathak SK; Pandey S; Pandey A; Salunke AA; Thivari P; Ratna HVK; Chawla J
    Diabetes Metab Syndr; 2020; 14(6):1873-1874. PubMed ID: 32998094
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients.
    Zayet S; Klopfenstein T; Mercier J; Kadiane-Oussou NJ; Lan Cheong Wah L; Royer PY; Toko L; Gendrin V
    Infection; 2021 Apr; 49(2):361-365. PubMed ID: 32410112
    [No Abstract]   [Full Text] [Related]  

  • 96. Relationship between Recovery from COVID-19-Induced Smell Loss and General and Oral Health Factors.
    Catton G; Gardner A
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208609
    [No Abstract]   [Full Text] [Related]  

  • 97. Electrophysiological and olfactometric evaluation of long-term COVID-19.
    Mazzatenta A; Montagnini C; Brasacchio A; Sartucci F; Neri G
    Physiol Rep; 2021 Sep; 9(18):e14992. PubMed ID: 34536067
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment.
    Varricchio A; La Mantia I; Brunese FP; Ciprandi G
    J Biol Regul Homeost Agents; 2021; 35(2):683-686. PubMed ID: 33728831
    [No Abstract]   [Full Text] [Related]  

  • 99. Use of Vinegar and Water to Identify COVID-19 Cases During a Workplace Entrance Screening Protocol.
    Kalia N; Moraga JA; Manzanares M; Friede V; Kusti M; Bernacki EJ; Tao XG
    J Occup Environ Med; 2021 Apr; 63(4):e184-e186. PubMed ID: 33769403
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Anosmia in the first coronavirus disease 2019 outbreak in Europe: functional recovery after eight months.
    Capelli M; Gatti P
    J Laryngol Otol; 2021 Mar; 135(3):224-228. PubMed ID: 33632353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.